Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	271.17	23.39	179.72	220.26	368.84
Depreciation & Amortization	40.23	39.85	35.71	19.51	13.83
Stock-Based Compensation	9.45	6.37	5.84	7.35	2.02
Other Adjustments	-99.75	126.01	-55.41	-52.26	-4
Change in Receivables	-6.95	-2.29	-20	9.79	-16.78
Changes in Inventories	-12.92	-6.81	-12	0.28	-
Changes in Accounts Payable	2.83	-4.59	3.78	0.09	-0.04
Changes in Accrued Expenses	-7.59	3.04	-2.44	12.12	-0.26
Changes in Income Taxes Payable	4.06	41.48	1.73	10.03	-
Changes in Unearned Revenue	3.14	-0.15	-0.82	-0.76	-
Changes in Other Operating Activities	-6.74	-37.62	4.96	-24.69	0.2
Operating Cash Flow	196.93	188.69	141.06	201.73	363.81
Operating Cash Flow Growth	4.37%	33.76%	-30.07%	-44.55%	16.19%
Capital Expenditures	-1.13	-0.27	-0.41	-0.07	-
Sale of Property, Plant & Equipment	0.01	0.1	-	-	-
Purchases of Intangible Assets	-9.37	-4	-	-	-
Purchases of Investments	-78.4	-91.89	-97.51	-169.64	-257.25
Proceeds from Sale of Investments	36.59	75.76	72.5	24.28	21.44
Payments for Business Acquisitions	-	-	-	-159.1	-
Proceeds from Business Divestments	-	-	-	248.19	-
Other Investing Activities	92.79	-43.49	-41.34	-0.3	279.53
Investing Cash Flow	40.5	-63.79	-66.76	-56.63	43.72
Long-Term Debt Issued	-	-	-	252.54	-
Long-Term Debt Repaid	-0.03	-	-96.2	-165.13	-
Net Long-Term Debt Issued (Repaid)	-0.03	-	-96.2	87.41	-
Issuance of Common Stock	13.25	1.47	0.17	0.37	1.17
Repurchase of Common Stock	-4.68	-14.92	-75.81	-8.59	-394.21
Net Common Stock Issued (Repurchased)	8.58	-13.45	-75.64	-8.22	-393.04
Other Financing Activities	-	-	-	-134.76	-59.46
Financing Cash Flow	8.55	-13.45	-171.84	-55.57	-452.5
Net Cash Flow	245.98	111.45	-97.54	89.52	-44.96
Free Cash Flow	195.8	188.42	140.65	201.66	363.81
Free Cash Flow Growth	3.92%	33.96%	-30.25%	-44.57%	16.20%
FCF Margin	47.60%	52.53%	45.30%	60.86%	92.84%
Free Cash Flow Per Share	2.31	2.54	1.62	2.12	3.86
Levered Free Cash Flow	293.03	58.33	114.02	317.84	279.59
Unlevered Free Cash Flow	213.53	264.27	152.82	175.41	324.45

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q